NTRA vs MEDP
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
NTRA
MEDP
Investment Advisor Scores
MEDP
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NTRA | MEDP | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 5000 | 33.1126 | MEDP |
| PEG Ratio | 0 | 3.3555 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 34.1% | 8.5% | NTRA |
| Earnings Growth | 0.0% | 25.4% | MEDP |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 64.8/100 | 53.9/100 | NTRA |
| Profit Margin | -5.7% | 18.2% | MEDP |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NTRA
NeutralMixed signals - no dominant trend phase, RSI 35
MEDP
MarkupPrice above SMA50, rising 50-day trend (3.7% over 20 days), RSI 53
Fundamentals Snapshot
| Metric | NTRA | MEDP |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -955.4 | 33.1 |
| Trailing P/E | — | 36.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.1% |
| Gross Margin | 0.7% | 0.7% |
| Operating Margin | -0.1% | 0.2% |
| EPS | -1.12 | 18.01 |
| Dividend Yield | — | — |